nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclobenzaprine—CYP2D6—Vinorelbine—ovarian cancer	0.114	0.255	CbGbCtD
Cyclobenzaprine—CYP3A4—Topotecan—ovarian cancer	0.103	0.23	CbGbCtD
Cyclobenzaprine—CYP3A4—Vinorelbine—ovarian cancer	0.0723	0.162	CbGbCtD
Cyclobenzaprine—CYP3A4—Paclitaxel—ovarian cancer	0.0508	0.114	CbGbCtD
Cyclobenzaprine—CYP2D6—Doxorubicin—ovarian cancer	0.0431	0.0964	CbGbCtD
Cyclobenzaprine—CYP3A4—Docetaxel—ovarian cancer	0.0367	0.0822	CbGbCtD
Cyclobenzaprine—CYP3A4—Doxorubicin—ovarian cancer	0.0274	0.0613	CbGbCtD
Cyclobenzaprine—Tamoxifen—CYP1B1—ovarian cancer	0.00105	0.207	CrCbGaD
Cyclobenzaprine—Vertigo—Paclitaxel—ovarian cancer	0.000886	0.00162	CcSEcCtD
Cyclobenzaprine—Syncope—Paclitaxel—ovarian cancer	0.000884	0.00161	CcSEcCtD
Cyclobenzaprine—Cerebrovascular accident—Doxorubicin—ovarian cancer	0.000884	0.00161	CcSEcCtD
Cyclobenzaprine—Leukopenia—Paclitaxel—ovarian cancer	0.000882	0.00161	CcSEcCtD
Cyclobenzaprine—Rash—Topotecan—ovarian cancer	0.000882	0.00161	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Vinorelbine—ovarian cancer	0.000881	0.00161	CcSEcCtD
Cyclobenzaprine—Dermatitis—Topotecan—ovarian cancer	0.000881	0.00161	CcSEcCtD
Cyclobenzaprine—Ataxia—Epirubicin—ovarian cancer	0.00088	0.0016	CcSEcCtD
Cyclobenzaprine—Headache—Topotecan—ovarian cancer	0.000876	0.0016	CcSEcCtD
Cyclobenzaprine—Protriptyline—ABCB1—ovarian cancer	0.000873	0.172	CrCbGaD
Cyclobenzaprine—Palpitations—Paclitaxel—ovarian cancer	0.000871	0.00159	CcSEcCtD
Cyclobenzaprine—Vomiting—Melphalan—ovarian cancer	0.000871	0.00159	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Paclitaxel—ovarian cancer	0.000866	0.00158	CcSEcCtD
Cyclobenzaprine—Osteoarthritis—Doxorubicin—ovarian cancer	0.000866	0.00158	CcSEcCtD
Cyclobenzaprine—Diplopia—Doxorubicin—ovarian cancer	0.000866	0.00158	CcSEcCtD
Cyclobenzaprine—Rash—Melphalan—ovarian cancer	0.000863	0.00157	CcSEcCtD
Cyclobenzaprine—Dermatitis—Melphalan—ovarian cancer	0.000862	0.00157	CcSEcCtD
Cyclobenzaprine—Asthenia—Vinorelbine—ovarian cancer	0.000858	0.00156	CcSEcCtD
Cyclobenzaprine—Arrhythmia—Docetaxel—ovarian cancer	0.000857	0.00156	CcSEcCtD
Cyclobenzaprine—Convulsion—Paclitaxel—ovarian cancer	0.000854	0.00156	CcSEcCtD
Cyclobenzaprine—Hypertension—Paclitaxel—ovarian cancer	0.000851	0.00155	CcSEcCtD
Cyclobenzaprine—Alopecia—Docetaxel—ovarian cancer	0.000848	0.00155	CcSEcCtD
Cyclobenzaprine—Pruritus—Vinorelbine—ovarian cancer	0.000846	0.00154	CcSEcCtD
Cyclobenzaprine—Myalgia—Paclitaxel—ovarian cancer	0.000839	0.00153	CcSEcCtD
Cyclobenzaprine—Chest pain—Paclitaxel—ovarian cancer	0.000839	0.00153	CcSEcCtD
Cyclobenzaprine—Anxiety—Paclitaxel—ovarian cancer	0.000836	0.00153	CcSEcCtD
Cyclobenzaprine—Face oedema—Doxorubicin—ovarian cancer	0.000836	0.00152	CcSEcCtD
Cyclobenzaprine—Nausea—Topotecan—ovarian cancer	0.000831	0.00151	CcSEcCtD
Cyclobenzaprine—Discomfort—Paclitaxel—ovarian cancer	0.000829	0.00151	CcSEcCtD
Cyclobenzaprine—Gastritis—Epirubicin—ovarian cancer	0.000828	0.00151	CcSEcCtD
Cyclobenzaprine—Dry mouth—Paclitaxel—ovarian cancer	0.000821	0.0015	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Vinorelbine—ovarian cancer	0.000818	0.00149	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Docetaxel—ovarian cancer	0.000818	0.00149	CcSEcCtD
Cyclobenzaprine—Ataxia—Doxorubicin—ovarian cancer	0.000814	0.00148	CcSEcCtD
Cyclobenzaprine—Nausea—Melphalan—ovarian cancer	0.000813	0.00148	CcSEcCtD
Cyclobenzaprine—Confusional state—Paclitaxel—ovarian cancer	0.000811	0.00148	CcSEcCtD
Cyclobenzaprine—Oedema—Paclitaxel—ovarian cancer	0.000805	0.00147	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000805	0.00147	CcSEcCtD
Cyclobenzaprine—Eosinophilia—Epirubicin—ovarian cancer	0.000801	0.00146	CcSEcCtD
Cyclobenzaprine—Shock—Paclitaxel—ovarian cancer	0.000792	0.00144	CcSEcCtD
Cyclobenzaprine—Dizziness—Vinorelbine—ovarian cancer	0.000791	0.00144	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000788	0.00144	CcSEcCtD
Cyclobenzaprine—Tachycardia—Paclitaxel—ovarian cancer	0.000785	0.00143	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000778	0.00142	CcSEcCtD
Cyclobenzaprine—Pancytopenia—Epirubicin—ovarian cancer	0.000768	0.0014	CcSEcCtD
Cyclobenzaprine—Anorexia—Paclitaxel—ovarian cancer	0.000767	0.0014	CcSEcCtD
Cyclobenzaprine—Gastritis—Doxorubicin—ovarian cancer	0.000766	0.0014	CcSEcCtD
Cyclobenzaprine—Vomiting—Vinorelbine—ovarian cancer	0.000761	0.00139	CcSEcCtD
Cyclobenzaprine—Rash—Vinorelbine—ovarian cancer	0.000754	0.00138	CcSEcCtD
Cyclobenzaprine—Dermatitis—Vinorelbine—ovarian cancer	0.000753	0.00137	CcSEcCtD
Cyclobenzaprine—Hypotension—Paclitaxel—ovarian cancer	0.000752	0.00137	CcSEcCtD
Cyclobenzaprine—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.000752	0.00137	CcSEcCtD
Cyclobenzaprine—Headache—Vinorelbine—ovarian cancer	0.000749	0.00137	CcSEcCtD
Cyclobenzaprine—Syncope—Docetaxel—ovarian cancer	0.000749	0.00137	CcSEcCtD
Cyclobenzaprine—Leukopenia—Docetaxel—ovarian cancer	0.000748	0.00136	CcSEcCtD
Cyclobenzaprine—Pollakiuria—Epirubicin—ovarian cancer	0.000747	0.00136	CcSEcCtD
Cyclobenzaprine—Eosinophilia—Doxorubicin—ovarian cancer	0.000741	0.00135	CcSEcCtD
Cyclobenzaprine—Palpitations—Docetaxel—ovarian cancer	0.000738	0.00135	CcSEcCtD
Cyclobenzaprine—Weight increased—Epirubicin—ovarian cancer	0.000736	0.00134	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Docetaxel—ovarian cancer	0.000734	0.00134	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000733	0.00134	CcSEcCtD
Cyclobenzaprine—Insomnia—Paclitaxel—ovarian cancer	0.000728	0.00133	CcSEcCtD
Cyclobenzaprine—Convulsion—Docetaxel—ovarian cancer	0.000724	0.00132	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Paclitaxel—ovarian cancer	0.000722	0.00132	CcSEcCtD
Cyclobenzaprine—Hypertension—Docetaxel—ovarian cancer	0.000721	0.00132	CcSEcCtD
Cyclobenzaprine—Drowsiness—Epirubicin—ovarian cancer	0.000721	0.00132	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Paclitaxel—ovarian cancer	0.000717	0.00131	CcSEcCtD
Cyclobenzaprine—Somnolence—Paclitaxel—ovarian cancer	0.000715	0.0013	CcSEcCtD
Cyclobenzaprine—Chest pain—Docetaxel—ovarian cancer	0.000711	0.0013	CcSEcCtD
Cyclobenzaprine—Myalgia—Docetaxel—ovarian cancer	0.000711	0.0013	CcSEcCtD
Cyclobenzaprine—Pancytopenia—Doxorubicin—ovarian cancer	0.000711	0.0013	CcSEcCtD
Cyclobenzaprine—Nausea—Vinorelbine—ovarian cancer	0.00071	0.0013	CcSEcCtD
Cyclobenzaprine—Tamoxifen—ESR1—ovarian cancer	0.000709	0.14	CrCbGaD
Cyclobenzaprine—Dyspepsia—Paclitaxel—ovarian cancer	0.000708	0.00129	CcSEcCtD
Cyclobenzaprine—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000707	0.00129	CcSEcCtD
Cyclobenzaprine—Jaundice—Epirubicin—ovarian cancer	0.000703	0.00128	CcSEcCtD
Cyclobenzaprine—Stomatitis—Epirubicin—ovarian cancer	0.000703	0.00128	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Paclitaxel—ovarian cancer	0.000699	0.00128	CcSEcCtD
Cyclobenzaprine—Dry mouth—Docetaxel—ovarian cancer	0.000696	0.00127	CcSEcCtD
Cyclobenzaprine—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000696	0.00127	CcSEcCtD
Cyclobenzaprine—Fatigue—Paclitaxel—ovarian cancer	0.000694	0.00126	CcSEcCtD
Cyclobenzaprine—Sweating—Epirubicin—ovarian cancer	0.000691	0.00126	CcSEcCtD
Cyclobenzaprine—Pollakiuria—Doxorubicin—ovarian cancer	0.000691	0.00126	CcSEcCtD
Cyclobenzaprine—Constipation—Paclitaxel—ovarian cancer	0.000688	0.00125	CcSEcCtD
Cyclobenzaprine—Confusional state—Docetaxel—ovarian cancer	0.000688	0.00125	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Docetaxel—ovarian cancer	0.000682	0.00124	CcSEcCtD
Cyclobenzaprine—Oedema—Docetaxel—ovarian cancer	0.000682	0.00124	CcSEcCtD
Cyclobenzaprine—Weight increased—Doxorubicin—ovarian cancer	0.000681	0.00124	CcSEcCtD
Cyclobenzaprine—Agranulocytosis—Epirubicin—ovarian cancer	0.000673	0.00123	CcSEcCtD
Cyclobenzaprine—Shock—Docetaxel—ovarian cancer	0.000671	0.00122	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Docetaxel—ovarian cancer	0.000668	0.00122	CcSEcCtD
Cyclobenzaprine—Drowsiness—Doxorubicin—ovarian cancer	0.000667	0.00122	CcSEcCtD
Cyclobenzaprine—Tachycardia—Docetaxel—ovarian cancer	0.000666	0.00121	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Paclitaxel—ovarian cancer	0.000663	0.00121	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000658	0.0012	CcSEcCtD
Cyclobenzaprine—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000654	0.00119	CcSEcCtD
Cyclobenzaprine—Stomatitis—Doxorubicin—ovarian cancer	0.00065	0.00119	CcSEcCtD
Cyclobenzaprine—Jaundice—Doxorubicin—ovarian cancer	0.00065	0.00119	CcSEcCtD
Cyclobenzaprine—Anorexia—Docetaxel—ovarian cancer	0.00065	0.00119	CcSEcCtD
Cyclobenzaprine—Hepatitis—Epirubicin—ovarian cancer	0.000647	0.00118	CcSEcCtD
Cyclobenzaprine—Hypoaesthesia—Epirubicin—ovarian cancer	0.000644	0.00117	CcSEcCtD
Cyclobenzaprine—Pharyngitis—Epirubicin—ovarian cancer	0.000643	0.00117	CcSEcCtD
Cyclobenzaprine—Sweating—Doxorubicin—ovarian cancer	0.00064	0.00117	CcSEcCtD
Cyclobenzaprine—Urticaria—Paclitaxel—ovarian cancer	0.000639	0.00117	CcSEcCtD
Cyclobenzaprine—Hypotension—Docetaxel—ovarian cancer	0.000637	0.00116	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Paclitaxel—ovarian cancer	0.000636	0.00116	CcSEcCtD
Cyclobenzaprine—Agranulocytosis—Doxorubicin—ovarian cancer	0.000623	0.00114	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000621	0.00113	CcSEcCtD
Cyclobenzaprine—Insomnia—Docetaxel—ovarian cancer	0.000617	0.00112	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Docetaxel—ovarian cancer	0.000612	0.00112	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Docetaxel—ovarian cancer	0.000608	0.00111	CcSEcCtD
Cyclobenzaprine—Somnolence—Docetaxel—ovarian cancer	0.000606	0.00111	CcSEcCtD
Cyclobenzaprine—Tinnitus—Epirubicin—ovarian cancer	0.000604	0.0011	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Docetaxel—ovarian cancer	0.0006	0.00109	CcSEcCtD
Cyclobenzaprine—Hepatitis—Doxorubicin—ovarian cancer	0.000599	0.00109	CcSEcCtD
Cyclobenzaprine—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000596	0.00109	CcSEcCtD
Cyclobenzaprine—Pharyngitis—Doxorubicin—ovarian cancer	0.000595	0.00108	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Docetaxel—ovarian cancer	0.000593	0.00108	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Paclitaxel—ovarian cancer	0.000593	0.00108	CcSEcCtD
Cyclobenzaprine—Fatigue—Docetaxel—ovarian cancer	0.000588	0.00107	CcSEcCtD
Cyclobenzaprine—Constipation—Docetaxel—ovarian cancer	0.000583	0.00106	CcSEcCtD
Cyclobenzaprine—Arrhythmia—Epirubicin—ovarian cancer	0.000578	0.00105	CcSEcCtD
Cyclobenzaprine—Asthenia—Paclitaxel—ovarian cancer	0.000577	0.00105	CcSEcCtD
Cyclobenzaprine—Alopecia—Epirubicin—ovarian cancer	0.000572	0.00104	CcSEcCtD
Cyclobenzaprine—Pruritus—Paclitaxel—ovarian cancer	0.000569	0.00104	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Docetaxel—ovarian cancer	0.000562	0.00102	CcSEcCtD
Cyclobenzaprine—Tinnitus—Doxorubicin—ovarian cancer	0.000559	0.00102	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000558	0.00102	CcSEcCtD
Cyclobenzaprine—Flatulence—Epirubicin—ovarian cancer	0.000555	0.00101	CcSEcCtD
Cyclobenzaprine—Tension—Epirubicin—ovarian cancer	0.000553	0.00101	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Epirubicin—ovarian cancer	0.000552	0.00101	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Paclitaxel—ovarian cancer	0.00055	0.001	CcSEcCtD
Cyclobenzaprine—Nervousness—Epirubicin—ovarian cancer	0.000547	0.000998	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Docetaxel—ovarian cancer	0.000539	0.000983	CcSEcCtD
Cyclobenzaprine—Arrhythmia—Doxorubicin—ovarian cancer	0.000535	0.000976	CcSEcCtD
Cyclobenzaprine—Dizziness—Paclitaxel—ovarian cancer	0.000532	0.00097	CcSEcCtD
Cyclobenzaprine—Vision blurred—Epirubicin—ovarian cancer	0.000531	0.000969	CcSEcCtD
Cyclobenzaprine—Alopecia—Doxorubicin—ovarian cancer	0.000529	0.000965	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Epirubicin—ovarian cancer	0.000523	0.000954	CcSEcCtD
Cyclobenzaprine—Agitation—Epirubicin—ovarian cancer	0.000518	0.000944	CcSEcCtD
Cyclobenzaprine—Flatulence—Doxorubicin—ovarian cancer	0.000514	0.000937	CcSEcCtD
Cyclobenzaprine—Tension—Doxorubicin—ovarian cancer	0.000512	0.000933	CcSEcCtD
Cyclobenzaprine—Vomiting—Paclitaxel—ovarian cancer	0.000512	0.000933	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Doxorubicin—ovarian cancer	0.000511	0.000931	CcSEcCtD
Cyclobenzaprine—Malaise—Epirubicin—ovarian cancer	0.000508	0.000927	CcSEcCtD
Cyclobenzaprine—Rash—Paclitaxel—ovarian cancer	0.000507	0.000925	CcSEcCtD
Cyclobenzaprine—Dermatitis—Paclitaxel—ovarian cancer	0.000507	0.000924	CcSEcCtD
Cyclobenzaprine—Nervousness—Doxorubicin—ovarian cancer	0.000506	0.000924	CcSEcCtD
Cyclobenzaprine—Vertigo—Epirubicin—ovarian cancer	0.000506	0.000923	CcSEcCtD
Cyclobenzaprine—Syncope—Epirubicin—ovarian cancer	0.000505	0.000922	CcSEcCtD
Cyclobenzaprine—Leukopenia—Epirubicin—ovarian cancer	0.000504	0.00092	CcSEcCtD
Cyclobenzaprine—Headache—Paclitaxel—ovarian cancer	0.000504	0.000919	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Docetaxel—ovarian cancer	0.000502	0.000916	CcSEcCtD
Cyclobenzaprine—Palpitations—Epirubicin—ovarian cancer	0.000498	0.000908	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Epirubicin—ovarian cancer	0.000495	0.000903	CcSEcCtD
Cyclobenzaprine—Vision blurred—Doxorubicin—ovarian cancer	0.000491	0.000896	CcSEcCtD
Cyclobenzaprine—Asthenia—Docetaxel—ovarian cancer	0.000489	0.000892	CcSEcCtD
Cyclobenzaprine—Convulsion—Epirubicin—ovarian cancer	0.000488	0.00089	CcSEcCtD
Cyclobenzaprine—Hypertension—Epirubicin—ovarian cancer	0.000487	0.000887	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000484	0.000882	CcSEcCtD
Cyclobenzaprine—Pruritus—Docetaxel—ovarian cancer	0.000482	0.00088	CcSEcCtD
Cyclobenzaprine—Chest pain—Epirubicin—ovarian cancer	0.00048	0.000875	CcSEcCtD
Cyclobenzaprine—Myalgia—Epirubicin—ovarian cancer	0.00048	0.000875	CcSEcCtD
Cyclobenzaprine—Agitation—Doxorubicin—ovarian cancer	0.000479	0.000874	CcSEcCtD
Cyclobenzaprine—Anxiety—Epirubicin—ovarian cancer	0.000478	0.000872	CcSEcCtD
Cyclobenzaprine—Nausea—Paclitaxel—ovarian cancer	0.000478	0.000871	CcSEcCtD
Cyclobenzaprine—Discomfort—Epirubicin—ovarian cancer	0.000474	0.000864	CcSEcCtD
Cyclobenzaprine—Malaise—Doxorubicin—ovarian cancer	0.00047	0.000858	CcSEcCtD
Cyclobenzaprine—Dry mouth—Epirubicin—ovarian cancer	0.000469	0.000856	CcSEcCtD
Cyclobenzaprine—Vertigo—Doxorubicin—ovarian cancer	0.000469	0.000854	CcSEcCtD
Cyclobenzaprine—Syncope—Doxorubicin—ovarian cancer	0.000468	0.000853	CcSEcCtD
Cyclobenzaprine—Leukopenia—Doxorubicin—ovarian cancer	0.000467	0.000851	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Docetaxel—ovarian cancer	0.000467	0.000851	CcSEcCtD
Cyclobenzaprine—Confusional state—Epirubicin—ovarian cancer	0.000464	0.000846	CcSEcCtD
Cyclobenzaprine—Palpitations—Doxorubicin—ovarian cancer	0.000461	0.00084	CcSEcCtD
Cyclobenzaprine—Oedema—Epirubicin—ovarian cancer	0.00046	0.000839	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Epirubicin—ovarian cancer	0.00046	0.000839	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Doxorubicin—ovarian cancer	0.000458	0.000836	CcSEcCtD
Cyclobenzaprine—Shock—Epirubicin—ovarian cancer	0.000453	0.000825	CcSEcCtD
Cyclobenzaprine—Convulsion—Doxorubicin—ovarian cancer	0.000452	0.000824	CcSEcCtD
Cyclobenzaprine—Dizziness—Docetaxel—ovarian cancer	0.000451	0.000822	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Epirubicin—ovarian cancer	0.00045	0.000821	CcSEcCtD
Cyclobenzaprine—Hypertension—Doxorubicin—ovarian cancer	0.00045	0.000821	CcSEcCtD
Cyclobenzaprine—Tachycardia—Epirubicin—ovarian cancer	0.000449	0.000819	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Epirubicin—ovarian cancer	0.000445	0.000811	CcSEcCtD
Cyclobenzaprine—Chest pain—Doxorubicin—ovarian cancer	0.000444	0.00081	CcSEcCtD
Cyclobenzaprine—Myalgia—Doxorubicin—ovarian cancer	0.000444	0.00081	CcSEcCtD
Cyclobenzaprine—Anxiety—Doxorubicin—ovarian cancer	0.000442	0.000807	CcSEcCtD
Cyclobenzaprine—Discomfort—Doxorubicin—ovarian cancer	0.000439	0.0008	CcSEcCtD
Cyclobenzaprine—Anorexia—Epirubicin—ovarian cancer	0.000438	0.0008	CcSEcCtD
Cyclobenzaprine—Dry mouth—Doxorubicin—ovarian cancer	0.000434	0.000792	CcSEcCtD
Cyclobenzaprine—Vomiting—Docetaxel—ovarian cancer	0.000434	0.000791	CcSEcCtD
Cyclobenzaprine—Rash—Docetaxel—ovarian cancer	0.00043	0.000784	CcSEcCtD
Cyclobenzaprine—Hypotension—Epirubicin—ovarian cancer	0.00043	0.000784	CcSEcCtD
Cyclobenzaprine—Dermatitis—Docetaxel—ovarian cancer	0.00043	0.000783	CcSEcCtD
Cyclobenzaprine—Confusional state—Doxorubicin—ovarian cancer	0.000429	0.000783	CcSEcCtD
Cyclobenzaprine—Headache—Docetaxel—ovarian cancer	0.000427	0.000779	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000426	0.000776	CcSEcCtD
Cyclobenzaprine—Oedema—Doxorubicin—ovarian cancer	0.000426	0.000776	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000419	0.000764	CcSEcCtD
Cyclobenzaprine—Shock—Doxorubicin—ovarian cancer	0.000419	0.000764	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000417	0.00076	CcSEcCtD
Cyclobenzaprine—Insomnia—Epirubicin—ovarian cancer	0.000416	0.000759	CcSEcCtD
Cyclobenzaprine—Tachycardia—Doxorubicin—ovarian cancer	0.000415	0.000757	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Epirubicin—ovarian cancer	0.000413	0.000753	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000411	0.00075	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Epirubicin—ovarian cancer	0.00041	0.000748	CcSEcCtD
Cyclobenzaprine—Somnolence—Epirubicin—ovarian cancer	0.000409	0.000746	CcSEcCtD
Cyclobenzaprine—Carbamazepine—ABCB1—ovarian cancer	0.000406	0.0802	CrCbGaD
Cyclobenzaprine—Anorexia—Doxorubicin—ovarian cancer	0.000406	0.00074	CcSEcCtD
Cyclobenzaprine—Nausea—Docetaxel—ovarian cancer	0.000405	0.000739	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Epirubicin—ovarian cancer	0.000405	0.000738	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Epirubicin—ovarian cancer	0.0004	0.000729	CcSEcCtD
Cyclobenzaprine—Hypotension—Doxorubicin—ovarian cancer	0.000398	0.000725	CcSEcCtD
Cyclobenzaprine—Fatigue—Epirubicin—ovarian cancer	0.000397	0.000723	CcSEcCtD
Cyclobenzaprine—Constipation—Epirubicin—ovarian cancer	0.000393	0.000717	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000388	0.000707	CcSEcCtD
Cyclobenzaprine—Insomnia—Doxorubicin—ovarian cancer	0.000385	0.000702	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Doxorubicin—ovarian cancer	0.000382	0.000697	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Doxorubicin—ovarian cancer	0.000379	0.000692	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Epirubicin—ovarian cancer	0.000379	0.000691	CcSEcCtD
Cyclobenzaprine—Somnolence—Doxorubicin—ovarian cancer	0.000378	0.00069	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000376	0.000686	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Doxorubicin—ovarian cancer	0.000375	0.000683	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Doxorubicin—ovarian cancer	0.00037	0.000675	CcSEcCtD
Cyclobenzaprine—Fatigue—Doxorubicin—ovarian cancer	0.000367	0.000669	CcSEcCtD
Cyclobenzaprine—Urticaria—Epirubicin—ovarian cancer	0.000365	0.000666	CcSEcCtD
Cyclobenzaprine—Constipation—Doxorubicin—ovarian cancer	0.000364	0.000664	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Epirubicin—ovarian cancer	0.000364	0.000663	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Doxorubicin—ovarian cancer	0.000351	0.00064	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000348	0.000635	CcSEcCtD
Cyclobenzaprine—Chlorprothixene—ABCB1—ovarian cancer	0.000341	0.0673	CrCbGaD
Cyclobenzaprine—Hypersensitivity—Epirubicin—ovarian cancer	0.000339	0.000618	CcSEcCtD
Cyclobenzaprine—Urticaria—Doxorubicin—ovarian cancer	0.000338	0.000617	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Doxorubicin—ovarian cancer	0.000336	0.000614	CcSEcCtD
Cyclobenzaprine—Asthenia—Epirubicin—ovarian cancer	0.00033	0.000602	CcSEcCtD
Cyclobenzaprine—Pruritus—Epirubicin—ovarian cancer	0.000325	0.000593	CcSEcCtD
Cyclobenzaprine—Trimipramine—ABCB1—ovarian cancer	0.000315	0.0622	CrCbGaD
Cyclobenzaprine—Diarrhoea—Epirubicin—ovarian cancer	0.000315	0.000574	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Doxorubicin—ovarian cancer	0.000314	0.000572	CcSEcCtD
Cyclobenzaprine—Asthenia—Doxorubicin—ovarian cancer	0.000305	0.000557	CcSEcCtD
Cyclobenzaprine—Dizziness—Epirubicin—ovarian cancer	0.000304	0.000555	CcSEcCtD
Cyclobenzaprine—Promethazine—ABCB1—ovarian cancer	0.000303	0.0599	CrCbGaD
Cyclobenzaprine—Pruritus—Doxorubicin—ovarian cancer	0.000301	0.000549	CcSEcCtD
Cyclobenzaprine—Tamoxifen—ABCB1—ovarian cancer	0.000301	0.0595	CrCbGaD
Cyclobenzaprine—Doxepin—ABCB1—ovarian cancer	0.0003	0.0593	CrCbGaD
Cyclobenzaprine—Vomiting—Epirubicin—ovarian cancer	0.000292	0.000533	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Doxorubicin—ovarian cancer	0.000291	0.000531	CcSEcCtD
Cyclobenzaprine—Rash—Epirubicin—ovarian cancer	0.00029	0.000529	CcSEcCtD
Cyclobenzaprine—Dermatitis—Epirubicin—ovarian cancer	0.00029	0.000528	CcSEcCtD
Cyclobenzaprine—Headache—Epirubicin—ovarian cancer	0.000288	0.000525	CcSEcCtD
Cyclobenzaprine—Dizziness—Doxorubicin—ovarian cancer	0.000281	0.000513	CcSEcCtD
Cyclobenzaprine—Nausea—Epirubicin—ovarian cancer	0.000273	0.000498	CcSEcCtD
Cyclobenzaprine—Vomiting—Doxorubicin—ovarian cancer	0.000271	0.000493	CcSEcCtD
Cyclobenzaprine—Rash—Doxorubicin—ovarian cancer	0.000268	0.000489	CcSEcCtD
Cyclobenzaprine—Dermatitis—Doxorubicin—ovarian cancer	0.000268	0.000489	CcSEcCtD
Cyclobenzaprine—Headache—Doxorubicin—ovarian cancer	0.000267	0.000486	CcSEcCtD
Cyclobenzaprine—Nausea—Doxorubicin—ovarian cancer	0.000253	0.000461	CcSEcCtD
Cyclobenzaprine—Imipramine—ABCB1—ovarian cancer	0.000234	0.0461	CrCbGaD
Cyclobenzaprine—Amitriptyline—ABCB1—ovarian cancer	0.000232	0.0459	CrCbGaD
